Centogene Historical Balance Sheet
CNTG Stock | USD 0.09 0.02 14.09% |
Trend analysis of Centogene B V balance sheet accounts such as Total Assets of 95.8 M, Short and Long Term Debt Total of 84.4 M or Other Current Liab of 10.6 M provides information on Centogene's total assets, liabilities, and equity, which is the actual value of Centogene B V to its prevalent stockholders. By breaking down trends over time using Centogene balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Centogene B V latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Centogene B V is a good buy for the upcoming year.
Centogene Inventory |
|
Centogene |
About Centogene Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Centogene B V at a specified time, usually calculated after every quarter, six months, or one year. Centogene Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Centogene and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Centogene currently owns. An asset can also be divided into two categories, current and non-current.
Centogene Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Centogene assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Centogene B V books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Centogene balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Centogene B V are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most accounts from Centogene's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Centogene B V current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At this time, Centogene's Other Current Liabilities is most likely to decrease significantly in the upcoming years. The Centogene's current Other Liabilities is estimated to increase to about 9.9 M, while Total Stockholder Equity is forecasted to increase to (24 M).
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 22.8M | 60.1M | 80.4M | 84.4M | Total Assets | 90.7M | 92.8M | 77.2M | 95.8M |
Centogene balance sheet Correlations
Click cells to compare fundamentals
Centogene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Centogene balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 117.5M | 150.1M | 90.7M | 92.8M | 77.2M | 95.8M | |
Short Long Term Debt Total | 27.0M | 24.1M | 22.8M | 60.1M | 80.4M | 84.4M | |
Other Current Liab | 13.1M | 20.5M | 19.6M | 10.1M | 8.6M | 10.6M | |
Total Current Liabilities | 29M | 57.1M | 39.5M | 24.7M | 43.4M | 36.5M | |
Total Stockholder Equity | 59.9M | 65.7M | 27.3M | 7.4M | (25.3M) | (24.0M) | |
Other Liab | 11.2M | 9.9M | 9.2M | 8.1M | 9.3M | 9.9M | |
Net Tangible Assets | 45.7M | 53.3M | 18.1M | 11K | 12.7K | 12.0K | |
Property Plant And Equipment Net | 33.3M | 38.7M | 27.1M | 22.2M | 19.3M | 23.4M | |
Net Debt | (9.6M) | (19.1M) | 9.4M | 28.1M | 61.3M | 64.4M | |
Retained Earnings | (40.6M) | (62.9M) | (109.3M) | (141.3M) | (177.4M) | (168.5M) | |
Accounts Payable | 8.6M | 31.7M | 11.3M | 6.3M | 5.6M | 11.0M | |
Cash | 36.6M | 43.2M | 13.4M | 32.0M | 19.1M | 21.7M | |
Non Current Assets Total | 49.4M | 53.1M | 39.2M | 33.0M | 33.2M | 32.4M | |
Non Currrent Assets Other | 1.9M | 2.0M | 3.0M | 3.4M | 3.4M | 4.9M | |
Other Assets | 0.0 | 1.9M | 2.0M | 3.0M | 3.4M | 3.6M | |
Long Term Debt | 12.9M | 1.6M | 401K | 40.1M | 39.9M | 41.9M | |
Cash And Short Term Investments | 36.6M | 43.2M | 13.4M | 32.0M | 19.1M | 21.7M | |
Net Receivables | 19.4M | 29.2M | 24.3M | 16.5M | 19.4M | 18.4M | |
Common Stock Total Equity | 262K | 322K | 2.4M | 2.7M | 3.1M | 3.2M | |
Common Stock Shares Outstanding | 16.4M | 20.9M | 22.4M | 26.8M | 28.2M | 24.0M | |
Liabilities And Stockholders Equity | 117.5M | 150.1M | 90.7M | 92.8M | 77.2M | 90.8M | |
Non Current Liabilities Total | 29.6M | 27.2M | 23.7M | 60.7M | 53.4M | 32.7M | |
Capital Lease Obligations | 21.7M | 21.2M | 19.0M | 15.4M | 14.6M | 13.5M | |
Inventory | 1.8M | 11.4M | 3.9M | 1.8M | 2.5M | 3.3M | |
Other Current Assets | 5.8M | 8.3M | 5.5M | 5.5M | 3.1M | 5.3M | |
Other Stockholder Equity | 106.5M | (851K) | 27.5M | 121.1M | 139.3M | 146.2M | |
Total Liab | 58.6M | 84.4M | 63.2M | 85.4M | 96.8M | 70.3M | |
Property Plant And Equipment Gross | 33.3M | 38.7M | 52.0M | 48.5M | 50.1M | 40.6M | |
Short Long Term Debt | 3.7M | 2.5M | 3.8M | 4.6M | 25.9M | 27.2M | |
Total Current Assets | 68.1M | 97.0M | 51.5M | 59.8M | 44.1M | 51.1M | |
Accumulated Other Comprehensive Income | 98.1M | 125.9M | 133.9M | 145.4M | 148.1K | 140.7K | |
Non Current Liabilities Other | 9.9M | 640K | 960K | 202K | 48K | 45.6K | |
Short Term Debt | 7.3M | 3.5M | 7.1M | 6.9M | 28.1M | 29.5M | |
Intangible Assets | 14.1M | 12.4M | 9.2M | 7.4M | 6.9M | 10.0M | |
Common Stock | 2.4M | 2.7M | 2.7M | 3.3M | 3.5M | 2.1M | |
Property Plant Equipment | 39.1M | 33.3M | 38.7M | 27.1M | 31.1M | 35.3M | |
Net Invested Capital | 65.1M | 68.6M | 31.1M | 52.1M | 40.5M | 52.5M | |
Net Working Capital | 39.1M | 39.9M | 12.0M | 35.2M | 653K | 620.4K |
Currently Active Assets on Macroaxis
When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) | Return On Equity (13.75) |
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.